Therapeutic strategy in patients with long-lasting essential hypertension with comorbid type 2 diabetes mellitus and obesity
| dc.contributor.author | Shelest, Borys | |
| dc.contributor.author | Hryhorian, Olena | |
| dc.contributor.author | Sarkis-Ivanova, Vladyslava | |
| dc.contributor.author | Kovalova, Yuliia | |
| dc.contributor.author | Brek, Valeria | |
| dc.contributor.author | Shelest, Oleksiy | |
| dc.date.accessioned | 2021-11-18T09:49:08Z | |
| dc.date.available | 2021-11-18T09:49:08Z | |
| dc.date.issued | 2021 | |
| dc.description.abstract | Presently the level of blood pressure (BP) control is extremely unsatisfactory in hypertensive patients throughout the world. The aim of our study was to find the optimal drug therapy for patients with hard-to-treat essential hypertension (EH) associated with type 2 diabetes mellitus (T2DM) and obesity, namely the comparison of strategies of fixed and non-fixed combination. | en_US |
| dc.identifier.citation | Therapeutic strategy in patients with long-lasting essential hypertension with comorbid type 2 diabetes mellitus and obesity / B. O. Shelest, O. V. Hryhorian, V. V. Sarkis-Ivanova, Y. O. Kovalova, V. V. Brek, O. M. Shelest // Arterial Hypertension. – 2021. – Vol. 25, N 1. – P. 39–46. | en_US |
| dc.identifier.uri | https://repo.knmu.edu.ua/handle/123456789/29773 | |
| dc.language.iso | en | en_US |
| dc.publisher | Via Medica | en_US |
| dc.subject | single-pill | en_US |
| dc.subject | comorbidity | en_US |
| dc.subject | essential hypertension | en_US |
| dc.subject | treatment | en_US |
| dc.title | Therapeutic strategy in patients with long-lasting essential hypertension with comorbid type 2 diabetes mellitus and obesity | en_US |
| dc.type | Article | en_US |